GS0401: Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
GS0051: Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer
GS0441: Medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
GS0421: Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
Case File Event Statements
6/13/2022 - 2 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
6/21/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
8/19/2022 - 2 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
8/23/2022 - 2 years ago
4 - SUSPENSION LETTER WRITTENType:CNSL
8/23/2022 - 2 years ago
5 - LETTER OF SUSPENSION E-MAILEDType:GNSL
8/23/2022 - 2 years ago
6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILEDType:GNS3
3/29/2023 - a year ago
7 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTIONType:RCCK
4/6/2023 - a year ago
9 - INQUIRY TO SUSPENSION E-MAILEDType:GNSI
4/6/2023 - a year ago
8 - SUSPENSION INQUIRY WRITTENType:CNSI
4/6/2023 - a year ago
10 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILEDType:GNS2
7/6/2023 - a year ago
11 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVEDType:ERSI
12/6/2023 - a year ago
12 - ASSIGNED TO LIEType:ALIE
12/6/2023 - a year ago
13 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
12/6/2023 - a year ago
14 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
12/6/2023 - a year ago
15 - SUSPENSION LETTER WRITTENType:CNSL
12/6/2023 - a year ago
16 - LETTER OF SUSPENSION E-MAILEDType:GNSL
12/6/2023 - a year ago
17 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILEDType:GNS3
10/28/2024 - 2 months ago
18 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTIONType:RCCK
11/13/2024 - 2 months ago
19 - SUSPENSION INQUIRY WRITTENType:CNSI
11/13/2024 - 2 months ago
20 - INQUIRY TO SUSPENSION E-MAILEDType:GNSI
11/13/2024 - 2 months ago
21 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILEDType:GNS2